CreditReports.dk
HomeScreen companies

PHARMACOSMOS A/S Financials, key figures and credit report

CVR number: 15517085 Established 1991 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Rørvangsvej 30, 4300 Holbæk tel: 59485959
Net sales 2 176.0 mDKK FY 2025 -17% vs 2024
EBIT margin 38.5 % FY 2025 -46.3 pp vs 2024
Net debt 76.0 mDKK FY 2025 -94.8% vs 2024
Quick ratio 2.0 FY 2025 -1 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales876.811 104.171 613.002 623.002 176.00
Other operating income1.144.73300.001 497.00
Costs of manufacturing- 331.36- 403.31- 368.00- 699.00- 800.00
Gross profit545.46700.851 245.002 093.001 577.00
Costs of management- 206.66- 244.19- 295.00- 411.00- 547.00
Costs of distribution- 127.84- 150.59- 174.00
Wages and salaries- 202.00
Social security expenses-19.00
Other operating expenses-33.85-96.00- 139.00- 242.00
EBIT210.95272.23917.002 225.00838.00
Other financial income139.6949.69152.00207.00190.00
Other financial expenses-46.47- 104.7830.00341.00- 238.00
Net income from associates (fin.)-74.15-55.95-63.00- 512.00299.00
Pre-tax profit231.15165.921 039.002 225.00838.00
Income taxes-61.11-51.64- 249.00- 603.00- 124.00
Net earnings170.04114.27790.001 622.00714.00

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure171.04100.7059.00
Intangible rights2 526.002 243.00
Intangible assets total171.04100.7059.002 526.002 243.00
Buildings7.00
Machinery and equipment5.284.35
Other tangible assets8.008.00
Tangible assets total5.284.357.008.008.00
Holdings in group member companies110.02107.2186.00
Other non-current investments-1.00
Investments total110.02107.2186.00
Non-current loans receivable82.00132.00
Long term receivables total82.00132.00
Raw materials and consumables20.6828.7929.0063.0076.00
Finished products/goods108.43118.55140.00160.00232.00
Advance payments14.007.00
Inventories total129.11147.34169.00237.00315.00
Current trade debtors123.26113.64236.00376.00234.00
Current amounts owed by group member comp.402.18606.651 033.00
Prepayments and accrued income2.763.88
Current other receivables3.527.1116.001 224.00962.00
Short term receivables total531.71731.291 285.001 600.001 196.00
Other current investments250.35235.56948.0065.00
Cash and bank deposits392.65427.00104.00205.00650.00
Cash and cash equivalents643.00662.561 052.00270.00650.00
Balance sheet total (assets)1 590.171 753.452 658.004 723.004 544.00

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital101.00101.00101.00101.00101.00
Shares repurchased300.00
Other reserves171.0478.5546.0063.0045.00
Retained earnings365.39560.77699.00411.001 615.00
Profit of the financial year170.04114.27790.001 622.00714.00
Shareholders equity total807.47854.591 636.002 197.002 775.00
Provisions25.217.06
Non-current loans from credit institutions432.64391.62328.001 321.00125.00
Non-current other liabilities537.00501.00
Non-current liabilities total432.64391.62328.001 858.00626.00
Current loans from credit institutions25.7141.41556.0076.00105.00
Advances received43.0034.00205.00
Current trade creditors17.0159.2260.0099.0074.00
Current owed to group member201.44326.40329.00496.00
Short-term deferred tax liabilities61.00161.00
Other non-interest bearing current liabilities22.8724.6735.0069.00102.00
Accruals and deferred income57.8148.48
Current liabilities total324.84500.18694.00668.001 143.00
Balance sheet total (liabilities)1 590.171 753.452 658.004 723.004 544.00
Page generated